The Niche

Stem cell warnings

Not so much a warning, but certainly bad news for Osiris. The mesenchymal stem cell drug Prochymal did not show efficacy in two large controlled study of graft versus host disease. ( Read that story here) 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE